Skip to content
This website uses cookies to help us understand the way visitors use our website. We can't identify you with them and we don't share the data with anyone else. If you click Reject we will set a single cookie to remember your preference. Find out more in our privacy policy.

Dementia: AHSC programme

Our AHSC (Academic Health Science Centre) drives pioneering research in prevention, early diagnosis, novel therapies and models of care to address this challenge of an estimated 72,000 Londoners are living with dementia.

According to the Health Vision for London, an estimated 72,000 Londoners are living with dementia, including around 3,700 people living with young onset dementia (onset under 65). If current trends continue, there will be a 40% increase in the people living with this condition by 2025. Our AHSC drives pioneering research in prevention, early diagnosis, novel therapies and models of care to address this challenge, working the UK Dementia Research Institute at UCL (ref: Healthy London).

  • UK Dementia Research Institute at UCL: The UK DRI operates across seven UK research centres, working together towards a shared vision. The hub of the research activities and operational headquarters is at UCL, selected due to its strength in bringing together excellent clinical and basic neuroscience research to advance understanding of neurodegeneration and identify novel targets and therapeutic approaches for dementia. https://www.ucl.ac.uk/uk-dementia-research-institute/
  • Dementia Research Centre (DRC): The DRC is a hub for patient-centred research into dementias. As well as clinical studies and trials in Alzheimer’s disease and other common causes of dementia, we have particular expertise in young-onset, inherited and unusual dementias. Our work focuses on identifying and understanding the disease processes that cause dementia, the factors that influence these disease processes, ways to improve diagnosis and treatments, and how best to support people with dementia and their families. Our research is closely integrated with the NHS Cognitive Disorders Service we run at The National Hospital for Neurology and Neurosurgery. https://www.ucl.ac.uk/drc/
  • The Alzheimer’s Research UK Drug Discovery Alliance couples disease knowledge and biology expertise of the academic community with high quality, innovative drug discovery technologies. http://ucl-ddi.alzheimersresearchuk.org/